Daiichi Sankyo UK Ltd

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets. With over 100 years of scientific expertise, we draw upon a rich legacy of innovation and a robust pipeline of promising new medicines. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, our research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases. For more information, please visit:

  • London PCN Event
  • Liverpool
  • Birmingham
  • Newcastle
  • Glasgow
  • Leeds